Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multicenter trial

Area of Science:

• Critical Care Medicine
• Infectious Disease Prevention
• Respiratory Therapy

Background:

• Ventilator-associated pneumonia (VAP) is a significant cause of patient morbidity and mortality.
• The effectiveness of subglottic secretion drainage (SSD) in preventing VAP is debated.

Purpose of the Study:

• To evaluate the efficacy of subglottic secretion drainage (SSD) in reducing the incidence of microbiologically confirmed ventilator-associated pneumonia (VAP).

Main Methods:

• A randomized controlled trial involving 333 adult patients requiring mechanical ventilation for ≥48 hours.
• Patients were assigned to intermittent SSD or a control group.
• VAP diagnosis was based on quantitative culture of distal pulmonary samples.

Main Results:

• Microbiologically confirmed VAP occurred in 14.8% of patients with SSD versus 25.6% in the control group (P=0.02), a 42.2% relative risk reduction.
• SSD significantly reduced both early-onset VAP (1.2% vs 6.1%, P=0.02) and late-onset VAP (18.6% vs 33.0%, P=0.01).
• No significant differences were found in mechanical ventilation duration or hospital mortality.

Conclusions:

• Subglottic secretion drainage is an effective method for significantly reducing VAP incidence in mechanically ventilated patients.
• SSD demonstrates particular benefit in preventing late-onset VAP.
• The findings support the use of SSD as a VAP prevention strategy.